nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—Gefitinib—Erlotinib—kidney cancer	0.273	0.504	CrCrCtD
Cisapride—Metoclopramide—Sunitinib—kidney cancer	0.269	0.496	CrCrCtD
Cisapride—CYP3A7—Temsirolimus—kidney cancer	0.0303	0.0728	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0303	0.0728	CbGbCtD
Cisapride—CYP3A5—Temsirolimus—kidney cancer	0.0227	0.0546	CbGbCtD
Cisapride—HTR2B—Sorafenib—kidney cancer	0.0217	0.0523	CbGbCtD
Cisapride—KCNH2—Sunitinib—kidney cancer	0.0146	0.0352	CbGbCtD
Cisapride—HTR2C—Sorafenib—kidney cancer	0.0142	0.0341	CbGbCtD
Cisapride—CYP2D6—Temsirolimus—kidney cancer	0.0139	0.0335	CbGbCtD
Cisapride—CYP3A4—Everolimus—kidney cancer	0.0131	0.0315	CbGbCtD
Cisapride—CYP2C8—Pazopanib—kidney cancer	0.0115	0.0276	CbGbCtD
Cisapride—CYP3A7—Paclitaxel—kidney cancer	0.0104	0.025	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0104	0.025	CbGbCtD
Cisapride—CYP3A7—Sorafenib—kidney cancer	0.00922	0.0222	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00922	0.0222	CbGbCtD
Cisapride—CYP3A7—Vincristine—kidney cancer	0.00895	0.0215	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00895	0.0215	CbGbCtD
Cisapride—CYP1A2—Pazopanib—kidney cancer	0.00888	0.0214	CbGbCtD
Cisapride—CYP3A4—Temsirolimus—kidney cancer	0.00885	0.0213	CbGbCtD
Cisapride—CYP2B6—Sorafenib—kidney cancer	0.00878	0.0211	CbGbCtD
Cisapride—CYP3A5—Erlotinib—kidney cancer	0.00851	0.0205	CbGbCtD
Cisapride—CYP2C9—Capecitabine—kidney cancer	0.00834	0.0201	CbGbCtD
Cisapride—CYP2C8—Erlotinib—kidney cancer	0.00818	0.0197	CbGbCtD
Cisapride—CYP3A5—Paclitaxel—kidney cancer	0.00779	0.0187	CbGbCtD
Cisapride—CYP2C8—Paclitaxel—kidney cancer	0.00749	0.018	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00747	0.018	CbGbCtD
Cisapride—CYP3A7—Sunitinib—kidney cancer	0.00747	0.018	CbGbCtD
Cisapride—CYP2D6—Pazopanib—kidney cancer	0.00731	0.0176	CbGbCtD
Cisapride—CYP3A5—Sorafenib—kidney cancer	0.00692	0.0166	CbGbCtD
Cisapride—CYP3A5—Vincristine—kidney cancer	0.00672	0.0162	CbGbCtD
Cisapride—CYP2C8—Sorafenib—kidney cancer	0.00665	0.016	CbGbCtD
Cisapride—CYP1A2—Erlotinib—kidney cancer	0.00633	0.0152	CbGbCtD
Cisapride—CYP3A5—Sunitinib—kidney cancer	0.00561	0.0135	CbGbCtD
Cisapride—CYP2C19—Sorafenib—kidney cancer	0.00558	0.0134	CbGbCtD
Cisapride—CYP2B6—Doxorubicin—kidney cancer	0.00533	0.0128	CbGbCtD
Cisapride—CYP2C9—Paclitaxel—kidney cancer	0.00522	0.0126	CbGbCtD
Cisapride—CYP2D6—Erlotinib—kidney cancer	0.00522	0.0126	CbGbCtD
Cisapride—CYP1A2—Sorafenib—kidney cancer	0.00515	0.0124	CbGbCtD
Cisapride—CYP3A4—Pazopanib—kidney cancer	0.00465	0.0112	CbGbCtD
Cisapride—CYP2C9—Sorafenib—kidney cancer	0.00464	0.0112	CbGbCtD
Cisapride—CYP2D6—Sorafenib—kidney cancer	0.00424	0.0102	CbGbCtD
Cisapride—CYP2D6—Vinblastine—kidney cancer	0.00419	0.0101	CbGbCtD
Cisapride—CYP3A4—Erlotinib—kidney cancer	0.00332	0.00798	CbGbCtD
Cisapride—CYP3A4—Paclitaxel—kidney cancer	0.00304	0.00731	CbGbCtD
Cisapride—CYP3A4—Sorafenib—kidney cancer	0.0027	0.00649	CbGbCtD
Cisapride—CYP3A4—Vinblastine—kidney cancer	0.00266	0.00641	CbGbCtD
Cisapride—CYP3A4—Vincristine—kidney cancer	0.00262	0.0063	CbGbCtD
Cisapride—CYP2D6—Doxorubicin—kidney cancer	0.00257	0.00619	CbGbCtD
Cisapride—CYP3A4—Sunitinib—kidney cancer	0.00219	0.00526	CbGbCtD
Cisapride—CYP3A4—Doxorubicin—kidney cancer	0.00164	0.00394	CbGbCtD
Cisapride—CYP2C19—urine—kidney cancer	0.0012	0.108	CbGeAlD
Cisapride—CYP1A2—urine—kidney cancer	0.00098	0.0884	CbGeAlD
Cisapride—CYP2C9—urine—kidney cancer	0.00093	0.0839	CbGeAlD
Cisapride—HTR2A—urine—kidney cancer	0.000766	0.0691	CbGeAlD
Cisapride—CYP3A4—urine—kidney cancer	0.000709	0.064	CbGeAlD
Cisapride—CYP2D6—urine—kidney cancer	0.000698	0.063	CbGeAlD
Cisapride—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000614	0.0555	CbGeAlD
Cisapride—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000526	0.0475	CbGeAlD
Cisapride—HTR2B—cortex of kidney—kidney cancer	0.00033	0.0298	CbGeAlD
Cisapride—KCNH2—renal system—kidney cancer	0.00028	0.0253	CbGeAlD
Cisapride—CYP2C8—renal system—kidney cancer	0.000256	0.0231	CbGeAlD
Cisapride—CYP3A5—nephron tubule—kidney cancer	0.000254	0.023	CbGeAlD
Cisapride—CYP2B6—nephron tubule—kidney cancer	0.000253	0.0228	CbGeAlD
Cisapride—KCNH2—cardiac atrium—kidney cancer	0.000251	0.0226	CbGeAlD
Cisapride—CYP2C8—kidney—kidney cancer	0.000248	0.0224	CbGeAlD
Cisapride—CYP1A2—renal system—kidney cancer	0.00024	0.0216	CbGeAlD
Cisapride—CYP3A5—renal system—kidney cancer	0.000231	0.0209	CbGeAlD
Cisapride—CYP2B6—renal system—kidney cancer	0.00023	0.0207	CbGeAlD
Cisapride—CYP3A5—kidney—kidney cancer	0.000224	0.0202	CbGeAlD
Cisapride—CYP2B6—kidney—kidney cancer	0.000222	0.02	CbGeAlD
Cisapride—CYP3A5—cortex of kidney—kidney cancer	0.000218	0.0196	CbGeAlD
Cisapride—CYP2B6—gonad—kidney cancer	0.000206	0.0186	CbGeAlD
Cisapride—HTR2A—renal system—kidney cancer	0.000187	0.0169	CbGeAlD
Cisapride—HTR2A—kidney—kidney cancer	0.000181	0.0164	CbGeAlD
Cisapride—CYP3A4—renal system—kidney cancer	0.000174	0.0157	CbGeAlD
Cisapride—CYP2D6—renal system—kidney cancer	0.000171	0.0154	CbGeAlD
Cisapride—HTR2A—gonad—kidney cancer	0.000168	0.0152	CbGeAlD
Cisapride—CYP3A4—kidney—kidney cancer	0.000168	0.0151	CbGeAlD
Cisapride—CYP2D6—kidney—kidney cancer	0.000165	0.0149	CbGeAlD
Cisapride—Gefitinib—CYP1A1—kidney cancer	3.38e-05	0.653	CrCbGaD
Cisapride—Gefitinib—ABCB1—kidney cancer	1.8e-05	0.347	CrCbGaD
Cisapride—CYP1A2—Metabolism—CRABP1—kidney cancer	4.17e-06	0.000135	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PSMD7—kidney cancer	4.17e-06	0.000135	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GSTP1—kidney cancer	4.17e-06	0.000135	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSTT1—kidney cancer	4.14e-06	0.000134	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ACHE—kidney cancer	4.14e-06	0.000134	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.1e-06	0.000133	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GSTP1—kidney cancer	4.07e-06	0.000132	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IGF2—kidney cancer	4.04e-06	0.000131	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CDKN2B—kidney cancer	4.02e-06	0.00013	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—APC—kidney cancer	3.98e-06	0.000129	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—KIT—kidney cancer	3.98e-06	0.000129	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IGF2—kidney cancer	3.97e-06	0.000128	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CDKN2B—kidney cancer	3.96e-06	0.000128	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—BCHE—kidney cancer	3.96e-06	0.000128	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—SCARB1—kidney cancer	3.95e-06	0.000128	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—ABCB1—kidney cancer	3.94e-06	0.000127	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—SCARB1—kidney cancer	3.92e-06	0.000127	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTGS1—kidney cancer	3.91e-06	0.000127	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—SLC5A5—kidney cancer	3.91e-06	0.000126	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IGF1R—kidney cancer	3.91e-06	0.000126	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ITPR2—kidney cancer	3.88e-06	0.000125	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTGS1—kidney cancer	3.88e-06	0.000125	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—ABCB1—kidney cancer	3.86e-06	0.000125	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IGF1R—kidney cancer	3.84e-06	0.000124	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PSMD7—kidney cancer	3.84e-06	0.000124	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GSTM1—kidney cancer	3.83e-06	0.000124	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—IL2—kidney cancer	3.82e-06	0.000124	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—MAPK3—kidney cancer	3.81e-06	0.000123	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PSMD7—kidney cancer	3.81e-06	0.000123	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CA9—kidney cancer	3.79e-06	0.000122	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—POMC—kidney cancer	3.79e-06	0.000122	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—SLC2A1—kidney cancer	3.77e-06	0.000122	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—RAF1—kidney cancer	3.76e-06	0.000122	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GSTM1—kidney cancer	3.74e-06	0.000121	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—BRAF—kidney cancer	3.74e-06	0.000121	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—IL2—kidney cancer	3.72e-06	0.00012	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—RAF1—kidney cancer	3.7e-06	0.00012	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.66e-06	0.000118	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—POMC—kidney cancer	3.66e-06	0.000118	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—IL2—kidney cancer	3.66e-06	0.000118	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HIF1A—kidney cancer	3.64e-06	0.000118	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—BCHE—kidney cancer	3.64e-06	0.000118	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TSC2—kidney cancer	3.63e-06	0.000117	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CYP1A1—kidney cancer	3.63e-06	0.000117	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—MAPK1—kidney cancer	3.63e-06	0.000117	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—BCHE—kidney cancer	3.61e-06	0.000117	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—SLC5A5—kidney cancer	3.6e-06	0.000116	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.58e-06	0.000116	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.58e-06	0.000116	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—SLC5A5—kidney cancer	3.56e-06	0.000115	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CYP1A1—kidney cancer	3.55e-06	0.000115	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ACHE—kidney cancer	3.54e-06	0.000114	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTT1—kidney cancer	3.54e-06	0.000114	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GSTP1—kidney cancer	3.53e-06	0.000114	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—KDR—kidney cancer	3.48e-06	0.000113	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—SLC2A1—kidney cancer	3.47e-06	0.000112	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—PIK3CA—kidney cancer	3.46e-06	0.000112	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—SLC2A1—kidney cancer	3.44e-06	0.000111	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—KRAS—kidney cancer	3.42e-06	0.000111	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—IL2—kidney cancer	3.37e-06	0.000109	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—POMC—kidney cancer	3.35e-06	0.000108	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—SCARB1—kidney cancer	3.35e-06	0.000108	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.34e-06	0.000108	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—ABCB1—kidney cancer	3.34e-06	0.000108	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—IL2—kidney cancer	3.32e-06	0.000107	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTGS1—kidney cancer	3.32e-06	0.000107	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PSMD7—kidney cancer	3.25e-06	0.000105	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GSTM1—kidney cancer	3.24e-06	0.000105	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CRABP1—kidney cancer	3.22e-06	0.000104	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HIF1A—kidney cancer	3.22e-06	0.000104	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—KIT—kidney cancer	3.21e-06	0.000104	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—APC—kidney cancer	3.21e-06	0.000104	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TSC2—kidney cancer	3.21e-06	0.000104	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.19e-06	0.000103	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HIF1A—kidney cancer	3.16e-06	0.000102	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TSC2—kidney cancer	3.16e-06	0.000102	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GSTP1—kidney cancer	3.15e-06	0.000102	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—PIK3CA—kidney cancer	3.15e-06	0.000102	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—RAF1—kidney cancer	3.12e-06	0.000101	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—RELA—kidney cancer	3.11e-06	0.0001	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—ERBB2—kidney cancer	3.09e-06	9.98e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—BCHE—kidney cancer	3.08e-06	9.96e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—KDR—kidney cancer	3.07e-06	9.94e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—MAPK3—kidney cancer	3.07e-06	9.93e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CYP1A1—kidney cancer	3.07e-06	9.93e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—POMC—kidney cancer	3.06e-06	9.87e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MTOR—kidney cancer	3.05e-06	9.85e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—SLC5A5—kidney cancer	3.05e-06	9.84e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—KDR—kidney cancer	3.03e-06	9.78e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—BRAF—kidney cancer	3.02e-06	9.75e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ITPR2—kidney cancer	3e-06	9.68e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ABCB1—kidney cancer	2.98e-06	9.63e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—SLC2A1—kidney cancer	2.94e-06	9.5e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—MAPK1—kidney cancer	2.92e-06	9.45e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTGS2—kidney cancer	2.92e-06	9.43e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.91e-06	9.41e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GSTP1—kidney cancer	2.9e-06	9.36e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GSTM1—kidney cancer	2.89e-06	9.35e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSTP1—kidney cancer	2.87e-06	9.28e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CDKN1B—kidney cancer	2.86e-06	9.24e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.85e-06	9.22e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—KIT—kidney cancer	2.83e-06	9.15e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—APC—kidney cancer	2.83e-06	9.15e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IL2—kidney cancer	2.8e-06	9.05e-05	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—PIK3CA—kidney cancer	2.79e-06	9.03e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—APC—kidney cancer	2.79e-06	9.01e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—KIT—kidney cancer	2.79e-06	9.01e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—KRAS—kidney cancer	2.76e-06	8.93e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.74e-06	8.86e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ABCB1—kidney cancer	2.74e-06	8.86e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ACHE—kidney cancer	2.73e-06	8.83e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTT1—kidney cancer	2.73e-06	8.83e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CCND1—kidney cancer	2.73e-06	8.82e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—JUN—kidney cancer	2.72e-06	8.8e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ABCB1—kidney cancer	2.72e-06	8.78e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—MAPK3—kidney cancer	2.71e-06	8.77e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—POMC—kidney cancer	2.71e-06	8.74e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CTNNB1—kidney cancer	2.7e-06	8.73e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—POMC—kidney cancer	2.7e-06	8.71e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTGS2—kidney cancer	2.68e-06	8.64e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—MAPK3—kidney cancer	2.67e-06	8.63e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—BRAF—kidney cancer	2.66e-06	8.6e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GSTM1—kidney cancer	2.66e-06	8.6e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—POMC—kidney cancer	2.65e-06	8.57e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—POMC—kidney cancer	2.65e-06	8.55e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSTM1—kidney cancer	2.64e-06	8.52e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PTEN—kidney cancer	2.63e-06	8.51e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—BRAF—kidney cancer	2.62e-06	8.47e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SCARB1—kidney cancer	2.59e-06	8.36e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—MAPK1—kidney cancer	2.58e-06	8.34e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTGS1—kidney cancer	2.56e-06	8.27e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTEN—kidney cancer	2.55e-06	8.23e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—MAPK1—kidney cancer	2.54e-06	8.21e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—PIK3CA—kidney cancer	2.54e-06	8.2e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.52e-06	8.16e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.52e-06	8.15e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—RAF1—kidney cancer	2.52e-06	8.14e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PSMD7—kidney cancer	2.51e-06	8.11e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—RELA—kidney cancer	2.51e-06	8.1e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.5e-06	8.08e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ERBB2—kidney cancer	2.49e-06	8.05e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.49e-06	8.04e-05	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	2.47e-06	7.97e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MTOR—kidney cancer	2.46e-06	7.95e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTP1—kidney cancer	2.45e-06	7.93e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—KRAS—kidney cancer	2.44e-06	7.88e-05	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—PIK3CA—kidney cancer	2.43e-06	7.84e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—KRAS—kidney cancer	2.4e-06	7.75e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—BCHE—kidney cancer	2.38e-06	7.69e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VEGFA—kidney cancer	2.38e-06	7.69e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.35e-06	7.6e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTEN—kidney cancer	2.33e-06	7.54e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ABCB1—kidney cancer	2.32e-06	7.5e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CDKN1B—kidney cancer	2.31e-06	7.46e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—POMC—kidney cancer	2.29e-06	7.4e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.27e-06	7.34e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL2—kidney cancer	2.26e-06	7.3e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTM1—kidney cancer	2.25e-06	7.28e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.25e-06	7.28e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MAPK3—kidney cancer	2.25e-06	7.27e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	2.24e-06	7.24e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—RAF1—kidney cancer	2.22e-06	7.18e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—RELA—kidney cancer	2.21e-06	7.15e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	2.2e-06	7.12e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CCND1—kidney cancer	2.2e-06	7.11e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ERBB2—kidney cancer	2.2e-06	7.11e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—JUN—kidney cancer	2.2e-06	7.1e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MYC—kidney cancer	2.19e-06	7.07e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—RAF1—kidney cancer	2.19e-06	7.07e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	2.18e-06	7.05e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—RELA—kidney cancer	2.18e-06	7.04e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MTOR—kidney cancer	2.17e-06	7.01e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ERBB2—kidney cancer	2.16e-06	6.99e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTGS2—kidney cancer	2.16e-06	6.98e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MAPK1—kidney cancer	2.14e-06	6.92e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.14e-06	6.91e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MTOR—kidney cancer	2.14e-06	6.9e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PTEN—kidney cancer	2.13e-06	6.87e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTGS2—kidney cancer	2.11e-06	6.82e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.05e-06	6.64e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—POMC—kidney cancer	2.05e-06	6.61e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CDKN1B—kidney cancer	2.04e-06	6.58e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—KRAS—kidney cancer	2.02e-06	6.54e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	2e-06	6.48e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL2—kidney cancer	1.99e-06	6.44e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL2—kidney cancer	1.96e-06	6.34e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCND1—kidney cancer	1.94e-06	6.28e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—JUN—kidney cancer	1.94e-06	6.27e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CTNNB1—kidney cancer	1.92e-06	6.22e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VEGFA—kidney cancer	1.92e-06	6.2e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCND1—kidney cancer	1.91e-06	6.18e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—JUN—kidney cancer	1.91e-06	6.17e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	1.89e-06	6.12e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTP1—kidney cancer	1.89e-06	6.12e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTEN—kidney cancer	1.88e-06	6.08e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—POMC—kidney cancer	1.88e-06	6.08e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PTEN—kidney cancer	1.88e-06	6.06e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—POMC—kidney cancer	1.86e-06	6.03e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	1.86e-06	6e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PTEN—kidney cancer	1.85e-06	5.96e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTEN—kidney cancer	1.84e-06	5.95e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTGS2—kidney cancer	1.83e-06	5.91e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK3—kidney cancer	1.82e-06	5.87e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TP53—kidney cancer	1.8e-06	5.81e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PIK3CA—kidney cancer	1.8e-06	5.8e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ABCB1—kidney cancer	1.79e-06	5.79e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MYC—kidney cancer	1.77e-06	5.71e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.76e-06	5.67e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTM1—kidney cancer	1.74e-06	5.62e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK1—kidney cancer	1.73e-06	5.58e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VEGFA—kidney cancer	1.69e-06	5.47e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VEGFA—kidney cancer	1.67e-06	5.39e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.65e-06	5.33e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PIK3CA—kidney cancer	1.65e-06	5.32e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—KRAS—kidney cancer	1.63e-06	5.27e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTGS2—kidney cancer	1.63e-06	5.27e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK3—kidney cancer	1.6e-06	5.18e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTEN—kidney cancer	1.59e-06	5.15e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—POMC—kidney cancer	1.59e-06	5.15e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK3—kidney cancer	1.58e-06	5.1e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MYC—kidney cancer	1.56e-06	5.04e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MYC—kidney cancer	1.53e-06	4.96e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK1—kidney cancer	1.52e-06	4.93e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK1—kidney cancer	1.5e-06	4.85e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTGS2—kidney cancer	1.5e-06	4.85e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	1.5e-06	4.84e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTGS2—kidney cancer	1.49e-06	4.81e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TP53—kidney cancer	1.45e-06	4.69e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—KRAS—kidney cancer	1.44e-06	4.65e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTEN—kidney cancer	1.42e-06	4.6e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—KRAS—kidney cancer	1.42e-06	4.58e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.33e-06	4.29e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CA—kidney cancer	1.32e-06	4.28e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTEN—kidney cancer	1.31e-06	4.23e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	1.3e-06	4.21e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.3e-06	4.19e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTEN—kidney cancer	1.3e-06	4.19e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TP53—kidney cancer	1.28e-06	4.14e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTGS2—kidney cancer	1.27e-06	4.11e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TP53—kidney cancer	1.26e-06	4.07e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—POMC—kidney cancer	1.23e-06	3.97e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.12e-06	3.63e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTEN—kidney cancer	1.11e-06	3.58e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CA—kidney cancer	1e-06	3.24e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTGS2—kidney cancer	9.81e-07	3.17e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CA—kidney cancer	9.23e-07	2.98e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CA—kidney cancer	9.15e-07	2.96e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTEN—kidney cancer	8.55e-07	2.76e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CA—kidney cancer	7.82e-07	2.53e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CA—kidney cancer	6.03e-07	1.95e-05	CbGpPWpGaD
